Clovis Oncology Inc (NASDAQ:CLVS)

5.95
Delayed Data
As of Aug 23
 +0.06 / +1.02%
Today’s Change
4.98
Today|||52-Week Range
37.21
-66.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.0078.0K55.5M95.4M
 
 
 
 
Cost of Goods Sold0.0070.0K9.2M17.5M
 
 
 
 
Depreciation And Amortization761.0K1.1M2.5M4.6M
 
 
 
 
 
 
Operating ExpensesGross Income-761.0K-1.1M43.8M73.3M
 
 
 
 
 
General Expenses299.0M290.7M281.4M407.1M
 
 
 
 
 
Research And Development269.3M251.1M142.5M231.3M
 
 
 
 
 
Total Operating Expenses299.8M291.9M293.1M429.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-299.8M-291.9M-237.6M-333.8M
 
 
 
 
 
Extraordinary Credit24.6M24.9M0.000.00
 
 
 
Extraordinary Charge-101.6M-105.8M-105.5M-28.0M
 
 
 
 
 
Interest Expense On Debt8.4M8.5M10.4M13.2M
 
 
 
 
 
Other Expenses3.2M53.0K3.6M7.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-381.9M-381.2M-350.0M-367.4M
 
 
 
 
 
Income Taxes-29.1M-32.0M-3.6M-608.0K
 
 
 
 
 
Net Income-352.9M-349.1M-346.4M-368.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS36.0M38.5M47.0M52.1M
 
 
 
 
 
Shares To Calculate EPS Diluted36.0M38.5M47.0M52.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$9.79-$9.07-$7.36-$7.07
 
 
 
 
 
EPS Diluted-$9.79-$9.07-$7.36-$7.07